Initial Experience in the Treatment of "Borderline Resectable" Pancreatic Adenocarcinoma.

The neoadjuvant treatment of APBR allows us to select a group of patients in whom resection achieves a longer survival to the group in which progression is observed. Post-adjuvant pancreatic resection requires vascular resection in most cases.